MILAN, Italy & HOUSTON, Texas--(BUSINESS WIRE)--Sorin S.p.A. (MIL:SRN), (MTA; Reuters Code: SORN.MI “Sorin”), a global medical device company and a leader in the treatment of cardiovascular diseases, and Cyberonics, Inc. (NASDAQ: CYBX, “Cyberonics”), a medical device company with core expertise in neuromodulation, today announced their respective designees to the Board of Directors of the combined company effective at the close of their proposed merger.
Help employers find you! Check out all the jobs and post your resume.
